PharmAla Biotech Holdings, Inc. (TSE:MDMA) has released an update.
PharmAla Biotech Holdings Inc., a biotech firm specializing in MDMA-related products, announces the successful closure of a $750,000 private placement. This financing will support the company’s patent acquisitions, product manufacturing, clinical trials, and general corporate needs. In parallel, the company has settled a $108,000 debt with shares to conserve cash for operational expenses.
For further insights into TSE:MDMA stock, check out TipRanks’ Stock Analysis page.
